# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-005928
Filing Date
2018-08-09
Accepted
2018-08-09 14:19:43
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | f10q_080818p.htm | 10-Q | 586101
2 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 9054
3 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 9347
4 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 3843
5 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 3764
| Complete submission text file | 0001171843-18-005928.txt |  | 4272952

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE FILE | bcrx-20180630.xml | EX-101.INS | 847342
7 | XBRL SCHEMA FILE | bcrx-20180630.xsd | EX-101.SCH | 48619
8 | XBRL CALCULATION FILE | bcrx-20180630_cal.xml | EX-101.CAL | 34586
9 | XBRL DEFINITION FILE | bcrx-20180630_def.xml | EX-101.DEF | 361377
10 | XBRL LABEL FILE | bcrx-20180630_lab.xml | EX-101.LAB | 327110
11 | XBRL PRESENTATION FILE | bcrx-20180630_pre.xml | EX-101.PRE | 367909

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 181004490
SIC: 2836 Biological Products, (No Diagnostic Substances)